| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/01/2007 | CA2188267C Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 05/01/2007 | CA2185394C Biotinderivate |
| 05/01/2007 | CA2162630C Sulfonamides |
| 05/01/2007 | CA2143636C Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 04/26/2007 | WO2007047820A1 Method for treating pain |
| 04/26/2007 | WO2007047725A2 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/26/2007 | WO2007047724A2 Compositions for lowering serum cholesterol and/or triglycerides |
| 04/26/2007 | WO2007047722A2 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/26/2007 | WO2007047718A2 Generation and use of vasculogenic tumors |
| 04/26/2007 | WO2007047575A2 Pharmacological treatments for sleep-related breathing disorders |
| 04/26/2007 | WO2007047327A2 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
| 04/26/2007 | WO2007046729A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose |
| 04/26/2007 | WO2007046456A1 Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 04/26/2007 | WO2007046426A1 Atr inhibitor |
| 04/26/2007 | WO2007046392A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/26/2007 | WO2007046353A1 Fibroblast activator, method for activation of fibroblast, collagen synthesis promoter, method for promotion of collagen synthesis, skin aging-preventing agent, and method for prevention of aging of the skin |
| 04/26/2007 | WO2006127930A3 Nk-b inhibitors for the treatment of muscular dystrophy |
| 04/26/2007 | WO2006067165A3 Indolidone derivatives for the treatment or prevention of fibrotic diseases |
| 04/26/2007 | US20070093535 Vinyl phenyl derivatives as GLK activators |
| 04/26/2007 | US20070093530 Substituted indolealkanoic acids |
| 04/26/2007 | US20070093518 Pharmaceutical compositions for the treatment of organophosphate poisoning |
| 04/26/2007 | US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies |
| 04/26/2007 | US20070093510 Phosphodiesterase 4 inhibitors |
| 04/26/2007 | US20070093506 Inhibitors of tyrosine kinases |
| 04/26/2007 | US20070093445 RNA interference mediating small RNA molecules |
| 04/26/2007 | US20070093427 Membrane-permeable NFAT inhibitory peptide |
| 04/26/2007 | US20070093416 Human beta-defensin secretion promoter |
| 04/26/2007 | US20070092566 Oral sustained-release tablet |
| 04/26/2007 | US20070092551 Therapeutic agent |
| 04/26/2007 | US20070092540 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof |
| 04/26/2007 | US20070092523 Combination Therapy Of Respiratory Diseases Using Antibodies |
| 04/26/2007 | US20070092504 Use of agents that modulate the interaction between PD-1 and its ligands in the downmodulation of immune responses |
| 04/26/2007 | US20070092499 Method for changing genetic properties of eukaryotic organism |
| 04/26/2007 | US20070092466 in combination with carrier, and optionally activity enhancer; arresting or reversing hair loss, or both, and promoting hair growth; also a mascara; thickening and darkening hair |
| 04/26/2007 | CA2626681A1 Atr inhibitor |
| 04/26/2007 | CA2626461A1 Compositions for lowering serum cholesterol and/or triglycerides |
| 04/26/2007 | CA2626441A1 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/26/2007 | CA2626422A1 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/26/2007 | CA2626330A1 Preventive or therapeutic agents for pancreatic cancer, ovarian cancer, or liver cancer comprising a novel water-solube prodrug |
| 04/26/2007 | CA2624492A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/25/2007 | EP1777519A1 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 04/25/2007 | EP1777225A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/25/2007 | EP1777223A1 Indole derivatives useful as histamine H3 antagonists |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776959A2 Use of HGF for the manufacture of a medicament for treating fibrotic disorders |
| 04/25/2007 | EP1776954A2 The use of inhibitors of the renin-angiotensin system for the treatment of stroke |
| 04/25/2007 | EP1776120A1 Novel uses of 2-phenyl-substituted imidazotriazinone derivatives |
| 04/25/2007 | EP1776114A1 Combinations of gaboxadol and 5ht2a antagonists |
| 04/25/2007 | EP1776096A2 Crp lowering agent |
| 04/25/2007 | EP1539147A4 Methods of treating microbial infections in humans and animals |
| 04/25/2007 | EP1499184A4 Methods and compositions for treating ectoparasite infestation |
| 04/25/2007 | EP1490401B1 Vegf peptides and their use |
| 04/25/2007 | EP1487834B1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1337267B1 Use of blood coagulation factor xiii for treating haemophilia a |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1254174B1 Human cyr61 |
| 04/25/2007 | EP1210948B1 Therapeutc peptide for nervous diseases |
| 04/25/2007 | EP1210425B1 Baff receptor (bcma), an immunoregulatory agent |
| 04/25/2007 | EP1209151B1 4-substituted piperidine derivatives |
| 04/25/2007 | EP1128833B1 Use of agonists of corticosteroid receptors and a drug to treat addiction |
| 04/25/2007 | EP1100780B1 2,3,3a,4,9,9a-HEXAHYDRO-8-HYDROXY-1H-BENZ[F]INDOLES, A METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS MEDICAMENTS |
| 04/25/2007 | EP1040101B1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953973A Preparation of candesartan cilexetil in high purity |
| 04/25/2007 | CN1953968A Thiazole compound and use thereof |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951504A Zinc finger protein HZF1 gene function and application thereof |
| 04/25/2007 | CN1951501A Pharmaceutical composition with Meclofenoxate hydrochloride capable of preventing hydrolysis |
| 04/25/2007 | CN1951436A Chinese medicinal composition for treating blood stasis syndrome caused by qi deficiency and preparation method thereof |
| 04/25/2007 | CN1951434A Soft capsule with broomrape and Chinese date having fatigue-resisting radiation-resisting function and preparation method thereof |
| 04/25/2007 | CN1951432A Gingseng and aconite composition, its preparation, preparation process and usage |
| 04/25/2007 | CN1951418A Chewing tablet of 'Yu Ping Feng' and preparation method thereof |
| 04/25/2007 | CN1951410A Protecting agent for brain cell or nerve cell, consisting of ginseng |
| 04/25/2007 | CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 04/25/2007 | CN1951391A Method for preparing suspension of rhodiola root nanoliposome |
| 04/25/2007 | CN1951376A Novel medical usage of protocatechualdehyde |
| 04/25/2007 | CN1951371A Immediate release tablet |
| 04/25/2007 | CN1951360A Complex salt crystal used for body surface physical therapy and preparation method thereof |
| 04/25/2007 | CN1312172C Use of tissue fibre proteinogen |
| 04/25/2007 | CN1312165C Aryl 5-thio-beta-D-glucopyranoside derivatives and remedies for diabetes containing the same |
| 04/25/2007 | CN1312154C Purine derivatives as kinase inhibitors |
| 04/25/2007 | CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 04/25/2007 | CN1312148C Isochroman compounds for treatment of CNS disorders |
| 04/25/2007 | CN1312147C Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 04/25/2007 | CN1312139C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/25/2007 | CN1312136C Triazole derivatives as tachykinin receptor antagonists |
| 04/25/2007 | CN1312129C Polymorphs of donepezil hydrochloride and process for production |
| 04/25/2007 | CN1312127C 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 04/25/2007 | CN1312120C Adamantane derivatives |
| 04/25/2007 | CN1312116C Calcium acceptor active compound |
| 04/25/2007 | CN1311870C Interleukin 6 production inhibitor |
| 04/25/2007 | CN1311834C Melanogenesis inhibitors and whitening agents comprising ergosterol derivatives and compositions containing ergosterol derivatives |
| 04/25/2007 | CN1311829C Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 04/25/2007 | CN1311821C Nerve fiber regeneration accelerator |
| 04/25/2007 | CN1311819C Crystalline composition containing escitalopram |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 04/24/2007 | US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein. |